Company Overview - LifeMD, Inc. is a leading provider of virtual primary care services, offering telemedicine, laboratory and pharmacy access, and specialized treatment for over 200 conditions [3] - The company utilizes a vertically integrated digital care platform, a 50-state affiliated medical group, and a 22,500-square-foot affiliated pharmacy to enhance access to high-quality and affordable care [3] Financial Reporting - LifeMD will report its financial results for the three months ended March 31, 2025, after the close of U.S. financial markets on May 6, 2025 [1] - A conference call will be held on the same day at 4:30 p.m. Eastern time to discuss the financial results [2] Contact Information - Investor inquiries can be directed to Marc Benathen, Chief Financial Officer, via email at marc@lifemd.com [4] - Media inquiries can be directed to Jessica Friedeman, Chief Marketing Officer, via email at press@lifemd.com [4]

Core Insights - LifeMD, Inc. has announced the acquisition of key assets from Optimal Human Health MD, marking its entry into the women's health market and establishing a scalable clinical foundation for a comprehensive virtual health program focused on hormone health, bone density, metabolism, and long-term wellness [1][2][3] Company Strategy - The expansion into women's health addresses significant unmet needs in areas such as perimenopause, menopause, and hormonal balance, which have historically been underserved [2][3] - LifeMD aims to leverage its national provider network, partnerships with Quest and Labcorp, in-house mail-order pharmacy, and behavioral health services to create a comprehensive virtual-first women's health offering [3][5] - The acquisition aligns with LifeMD's broader strategy of scaling high-demand specialty care verticals, following the success of its men's health initiative, Rex MD [5] Market Opportunity - The women's health market, particularly in menopause and osteoporosis, represents a projected opportunity of $60–70 billion by 2030, highlighting the urgency for solutions that cater to women's health needs at every life stage [2][4] Team and Expertise - The acquisition brings Optimal's trained team, including nurse practitioners and registered dietitians, as well as Dr. Doug Lucas, a respected leader in osteoporosis reversal and hormone optimization, to LifeMD [4][5] - Dr. Lucas will play a central role in shaping LifeMD's women's health strategy, leveraging his clinical experience and thought leadership [4][5]

Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, while investors want to cash in by putting their hard-earned money into the most promising AI companies. However, prominent names in this fast-growing space have seen their shares soar in the past two years, and the valuations of some have become quite expensive. Two AI healthcare stocks -- Recursion Pharmaceuticals (RXRX -2.76%) and Teladoc Health (TDOC -5.20%) -- have lagged the mar ...